Marshall Wace
AERI

Marshall Wace’s Aerie Pharmaceuticals AERI Stock Holding History

Marshall Wace’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-434,525
Closed -$3.26M – 3987
2022
Q2 		$3.26M Buy
434,525
+305,951
+238% +$2.16M 0.01% 1666
2022
Q1 		$1.17M Buy
+128,574
New +$991K ﹤0.01% 2377
2020
Q2 		– Sell
-24,165
Closed -$326K – 2067
2020
Q1 		$326K Buy
+24,165
New +$458K ﹤0.01% 1073
2019
Q2 		– Sell
-8,470
Closed -$402K – 1984
2019
Q1 		$402K Sell
8,470
-4,612
-35% -$203K ﹤0.01% 1197
2018
Q4 		$472K Buy
+13,082
New +$614K ﹤0.01% 1116
2018
Q2 		– Sell
-6,200
Closed -$336K – 888
2018
Q1 		$336K Buy
+6,200
New +$347K 0.01% 450

Other funds holding AERI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace's AERI Position: Q3 2022 in Review

Marshall Wace sold out of Aerie Pharmaceuticals (AERI) in Q3 2022, closing a stake of 434,525 shares — an estimated $3.26M sold.

Marshall Wace first reported a position in AERI in Q1 2018 and held it in 6 quarters. The position peaked at $3.26M in Q2 2022. 156 funds tracked by Wall St. Rank hold AERI as of Q3 2022.

  • Marshall Wace reported no remaining Aerie Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Marshall Wace sold 434,525 Aerie Pharmaceuticals shares in Q3 2022, an estimated $3.26M.
  • Marshall Wace first reported a position in Aerie Pharmaceuticals in Q1 2018 and held it in 6 quarters.
  • Marshall Wace's Aerie Pharmaceuticals position peaked at $3.26M in Q2 2022.
  • 156 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2022.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.